98%
921
2 minutes
20
Aim: Lactation is an important programming window for metabolic disease and neuronal alterations later in life. We aimed to study the effect of maternal glycation during lactation on offspring neurodevelopment and behaviour, assessing possible sex differences and underpinning molecular players.
Methods: Female Wistar rats were treated with Glyoxalase-1 inhibitor S-p-Bromobenzylguthione cyclopentyl diester (BBGC 5 mg/kg). A control and vehicle group treated with dimethyl sulfoxide were also considered. Male and female offspring were tested at infancy for neurodevelopment hallmarks. After weaning, triglycerides and total antioxidant capacity were measured in breast milk. At adolescence, offspring were tested for locomotor ability, anxious-like behaviour, and recognition memory. Metabolic parameters were assessed, and the hippocampus and prefrontal cortex were collected for molecular analysis.
Key Findings: Maternal glycation reduced triglycerides and total antioxidant capacity levels in breast milk. At infancy, both male and female offspring presented an anticipation on the achievement of neurodevelopmental milestones. At adolescence, male offspring exposed to maternal glycation presented hyperlocomotion, whereas offspring of both sexes presented a risk-taking phenotype, accompanied by increase GABA receptor levels in the hippocampus. Females also demonstrated GABA and PSD-95 changes in prefrontal cortex. Furthermore, lower levels of GLO1 and consequently higher accumulation of AGES were also observed in both male and female offspring hippocampus.
Significance: Early exposure to maternal glycation induces changes in milk composition leading to neurodevelopment changes at infancy, and sex-specific behavioural and neurometabolic changes at adolescence, further evidencing that lactation period is a critical metabolic programming window and in sculpting behaviour.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.lfs.2023.121597 | DOI Listing |
Diabetes Metab Res Rev
September 2025
Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Aim: Our aim was to ascertain whether metformin can reduce insulin requirement without compromising glycaemic control during pregnancy in women with type 1 diabetes.
Methods: A total of 126 pregnant women with type 1 diabetes were recruited for a randomised, double-blind, placebo-controlled multicentre study. The primary outcome was total insulin change, defined as the difference between baseline and third trimester maximum insulin dose (IU).
Saudi Med J
September 2025
From the Department of Biochemistry (Thalapalliyil, Bobby), from the Department of Obstetrics and Gynecology (Dorairajan), and from the Department of Pathology (Ch. Toi), JIPMER, Puducherry, India.
Objectives: To explore whether uniform supplementation causes iron overload among a cohort of South Indian non-anemic pregnant women with diabetes-in-pregnancy (DIP).
Methods: The study took place between May 2022 and May 2024 and consisted of 120 participants from 2 groups: healthy pregnant women (HP) and pregnant women with DIP. Levels of Hb and the serum indices of iron homeostasis-iron, unsaturated iron-binding capacity, total iron-binding capacity, transferrin saturation, ferritin, hepcidin, soluble transferrin receptor (sTfR), and sTfR index, were estimated.
Pharmaceuticals (Basel)
August 2025
Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.
The effect of metformin on the secretory function of thyrotropic cells is sex-dependent. The current study aimed to investigate whether the impact of this drug on activity of the hypothalamic-pituitary-thyroid axis in women is impacted by the androgen status of patients. The study population included 48 levothyroxine-naïve reproductive-aged women with subclinical hypothyroidism and prediabetes receiving 3.
View Article and Find Full Text PDFBMJ Open Diabetes Res Care
August 2025
Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota, USA
Introduction: Early birth is often recommended for "poorly controlled" diabetes; however, no guidelines define the glycemic threshold that necessitates delivery. We use natural language processing (NLP) of electronic health records to identify individuals described by healthcare professionals as having "poor glucose control" and to examine the factors and outcomes associated with this categorization RESEARCH DESIGN AND METHODS: We completed a retrospective cohort study of pregnant individuals with pre-existing and gestational diabetes mellitus from 2018 to 2019. NLP identified prespecified terms indicating "poor glucose control" in clinical notes, and a cohort analysis compared those with and without "poor glucose control" language.
View Article and Find Full Text PDFDiabetes Metab Syndr Obes
August 2025
Department of Obstetrics, Shijiazhuang Maternal and Child Health Hospital, Shijiazhuang, 050000, People's Republic of China.
Purpose: To evaluate the predictive efficacy of serum D-Dimer (D-D), Glycated Serum Protein (GSP), and HbA1c levels for macrosomia in Gestational Diabetes Mellitus (GDM).
Methods: A retrospective analysis was conducted on 224 pregnant women diagnosed with GDM from January 2021 to July 2024. Based on neonatal birth weight, 112 women were assigned to the macrosomia group, and 112 women with normal birth weight infants were assigned to the normal group.